A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or refractory multiple myeloma remained in remission for at least five years ...

Here, we describe an approach using a different variant of CAR T cells for multiple myeloma that holds promise for those with treatment-resistant forms of the disease. What is Multiple Myeloma?

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

CAR T-cell therapy is a type of immunotherapy used to treat multiple myeloma when other therapies have failed. It has improved remission and survival times, but long-term data on safety and ...

Researchers sought to determine whether CAR-T therapy could improve HR-QoL scores for patients with relapsed or refractory multiple myeloma.

Early study results from the UNIVERSAL clinical trial test a promising solution: a ready-made version of CAR T therapy for multiple myeloma. The treatment shows encouraging safety and efficacy ...

What Is Refractory Multiple Myeloma? Multiple myeloma is a cancer that affects a type of white blood cell called a plasma cell, which helps your immune system fight infections. Refractory means ...

Dr. Sham Mailankody says the new type of CAR T cell therapy could enable people with multiple myeloma to receive treatment faster. The first off-the-shelf (allogeneic) CAR T cell therapy for multiple ...

Multiple myeloma, a rare blood cancer, now has many treatment options. A new CAR T cell therapy targeting an antigen called GPRC5D appears to be safe and effective. For people with multiple myeloma, ...

An emerging form of treatment is chimeric antigen receptor (CAR) T cell therapy. Multiple myeloma is a type of plasma cell neoplasm, a form of cancer that affects cells of the immune system.

“When we think about how far we’ve come in multiple myeloma, we’re so excited about the potential power of CAR T-cell therapy. This is a one time treatment that we know can have very deep ...

Fred Hutch is an internationally recognized center for multiple myeloma, with the most advanced diagnostic, treatment and recovery programs. Because of our innovation and research programs, patients ...